Shares of Vertex Pharmaceuticals (VRTX) surged more than 42% Tuesday on volume that is already 11 times above the daily average after the company said two Phase III trials for its cystic fibrosis ...

(Reuters) - Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments. The drugmaker now expects 2024 ...

Vertex Pharmaceuticals Inc. raised its sales expectations for the year, citing continued growth of its cystic fibrosis drugs and the launch of its new treatment for sickle cell disease. Vertex now ...

(Reuters) - An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals/CRISPR Therapeutics and bluebird bio to as much as $2.05 ...

US manufacturer Lift-A-Loft has unveiled a new compact vertical mast lift, called Vertex. Vertex can elevate to 12 ft (3.6 m) of platform height allowing a working height of 18 ft (5.5 m). The compact ...

Shares of biotechnology firm Vertex Pharmaceuticals (NASDAQ:VRTX) are soaring by more than 55 percent early Friday and have touched a new all-time high after the company announced late Thursday that ...